Tuesday, April 20, 2021

FDA overdue on guidance as DSCSA deadline looms - RAPS.org

According to the article:

"Legal experts advised the pharmaceutical industry to start preparing now to meet the November 2023 deadline for having fully electronic interoperable systems in place for tracking  products through the supply chain under the Drug Supply Chain Security Act (DSCSA).

Food and drug law attorneys outlined ways the industry can meet these requirements at a 15 April traceability forum on DSCSA implementation sponsored by the Healthcare Distributors Association (HDA)."

Read the full source article:  FDA overdue on guidance as DSCSA deadline looms - RAPS.org

You might also be interested in:  Drug Supply Chain Security Act Law and Policies - FDA.gov

Return to SkillsPlus International Info Blog - Home

SkillsPlus Intl Inc. - The Best GMP Training & cGMP Training Around
Free GMP Training Tips
Root Cause Analysis - GMP Training
Deviation Investigation Report Writing - GMP Training
Qualstar Simulation - Advanced GMP Training That's Fun!

 

Thursday, April 15, 2021

Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the COVID-19 Public Health Emergency | Guidance for Industry - FDA.gov

According to the guidance document:

"FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support response efforts to this pandemic.

FDA is issuing this guidance to describe how we will request and conduct voluntary remote interactive evaluations at facilities where drugs are manufactured, processed, packed, or held; facilities covered under FDA's bioresearch monitoring (BIMO) program; and outsourcing facilities registered under section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act) for the duration of the COVID-19 public health emergency.

This policy is intended to remain in effect only for the duration of the public health emergency related to COVID-19 declared by the Secretary of Health and Human Services (HHS) on January 31, 2020, effective January 27, 2020, including any renewals made by the HHS Secretary in accordance with section 319(a)(2) of the Public Health Service Act (PHS Act) (42 U.S.C. 247d(a)(2))."

View the full source document: Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the COVID-19 Public Health Emergency Guidance for Industry - FDA.gov (PDF)

Return to SkillsPlus International Info Blog - Home

SkillsPlus Intl Inc. - The Best GMP Training & cGMP Training Around
Free GMP Training Tips
Root Cause Analysis - GMP Training
Deviation Investigation Report Writing - GMP Training
Qualstar Simulation - Advanced GMP Training That's Fun!

 

Thursday, April 1, 2021

California Designated Representative 3PL Course

SkillsPlus International Inc. is the ONLY Board-approved provider of all three of the following online training programs.

Updated February 27, 2026:

California Designated Representative-3PL Training Course

If you are applying for a California Designated Representative 3PL license, then you’re also going to need to include proof of required training (specifically, a training affidavit) in your California Designated Representative-3PL license application packet. Earn a training affidavit by taking any of our California Designated Representative training courses.

About this online training course:

  • Price: $525 per student
  • Enter our online classroom to take the course. Available 24 x 7.
  • This course is approved by the California State Board of Pharmacy.
  • The course covers all required topics specified in the Board's license application.
  • Successful course completion earns a training affidavit accepted by the Board, to include in your California Designated Representative 3PL license application.
  • Sign-Up Now! California Designated Representative 3PL online training course

 

California Designated Representative-3PL Training Course. Image of a glowing blue laptop against a dark background.
Register for this class, California Designated Representative-3PL Training Course.
Earns a training affidavit accepted by the California Board of Pharmacy.

Tuesday, March 2, 2021

Drug industry pushes FDA to solve growing inspection backlog - Politico

 AD - FDA GMP Online Training Courses by SkillsPlus Intl Inc. - AD

I had to read this snippet very carefully, and re-read it several times to make sure I completely understood the statistics reported. I suggest you do the same.

According to the article:

"From March through September, FDA inspected just three plants outside the U.S., well below the 600-plus it visited in each of the prior two years, the Government Accountability Office said last month. FDA has also struggled to keep up with inspections within U.S. borders, conducting just 52 during the same seven-month period last year, compared with roughly 400 each in 2019 and 2018."

Read the full source article: Drug industry pushes FDA to solve growing inspection backlog - Politico

Return to SkillsPlus International Info Blog - Home

SkillsPlus Intl Inc. - The Best GMP Training & cGMP Training Around
Free GMP Training Tips
Root Cause Analysis - GMP Training
Deviation Investigation Report Writing - GMP Training
Qualstar Simulation - Advanced GMP Training That's Fun!

 

Wednesday, February 3, 2021

FDA names its first medical device cybersecurity director - Fierce Biotech

According to the article:

"The FDA has appointed its first medical device cybersecurity chief to help guide the agency’s regulatory strategies as more devices become interconnected—and potentially more vulnerable to digital attacks and breaches.

Kevin Fu, an associate professor and research fellow at the University of Michigan, was named to the post. He will serve a one-year term as an expert-in-residence at the agency’s Center for Devices and Radiological Health (CDRH) as well as at its nascent Digital Health Center of Excellence, which launched last fall."

Read the full source article:  FDA names its first medical device cybersecurity director - Fierce Biotech

Return to SkillsPlus International Info Blog - Home

-----

FDA GMP QSR cGMP Online Training - recommended GMP online training courses offered by SkillsPlus International Inc.
FDA GMP QSR cGMP Online Training - recommended GMP online training courses offered by SkillsPlus International Inc. 

SkillsPlus Intl Inc. - The Best GMP Training & cGMP Training Around
Free GMP Training Tips
Root Cause Analysis - GMP Training
Deviation Investigation Report Writing - GMP Training
Qualstar Simulation - Advanced GMP Training That's Fun!

 

Thursday, January 28, 2021

Exemptee License Training - California Exemptee Certification

Exemptee License Training - California Exemptee Certification

An online training program for home medical device retailer Exemptee license applicants and their supervisors - California Exemptee License Training Certification Course - learn more & buy

California home medical device retail law requires companies carrying items needing a prescription to have an Exemptee (or pharmacist) responsible for the distribution of these items. In order to be in regulatory compliance, the company's Exemptee(s) must complete required training approved and accepted by the California Department of Public Health (CDPH) - Food and Drug Branch.

Such an Exemptee course is offered by SkillsPlus International Inc. and is recognized by the CDPH. Successful course completion earns a course completion certificate suitable for your Exemptee license application submission.

Details About Our California HMDR Exemptee Training Course

  • Learn more and buy now | California Exemptee Training
  • $525 per student - no extra fees to retake any of the quizzes
  • Recognized by the CDPH.  By the way, the Exemptee license application asks, "Have you completed training program(s) that address the following: (Attach copy of completed training certificate) …"
  • This course covers all topics specified in the license application.
  • The online classroom is open 24 x 7 for your convenience. Come and go as needed.
  • We've added something new, closed captioning. Students can read what the course instructor is teaching. This feature helps ESL (English as a second language) students, and hard of hearing students. 
  • Highly recommended, offered continuously since 2002.
Return to SkillsPlus International Info Blog - Home

-----

California HMDR Exemptee License Training. California Exemptee training certification course for home medical device retail license applicants and their managers. Recognized by the California Department of Public Health - Food and Drug Branch.
California HMDR Exemptee License Training. California Exemptee training certification course for home medical device retail license applicants and their managers. Recognized by the California Department of Public Health - Food and Drug Branch. 

Tuesday, January 19, 2021

Top pharma industry predictions for 2021 - Pharma Manufacturing

According to the article:

"Perhaps more than most other industries, the landscape of pharma was radically altered by the pandemic. Now, with an end to the coronavirus within reach, experts say that the industry will soon be taking stock of how it navigated the pandemic and what the sudden shifts in operations and regulations could mean in the long-term. 

Here’s a look at some of the top trends experts say will impact the industry in 2021 and predictions about how the pandemic could permanently change life in pharma."

The predictions are categorized by:

  • Therapeutic innovations
  • Manufacturing capacity
  • Supply chain
  • Manufacturing technologies
  • Drug development
  • Regulatory changes, and
  • Market trends

            Read the full source article: Top pharma industry predictions for 2021 - Pharma Manufacturing



            FDA GMP QSR cGMP Online Training - GMP online training courses offered by SkillsPlus International Inc.

            Thursday, January 14, 2021

            FDA Veteran Woodcock Being Considered to Lead Agency Under Biden - Bloomberg News

            According to the article:

            "Janet Woodcock, a 30-year veteran of the Food and Drug Administration, is being considered by President-elect Joe Biden to serve as commissioner of the agency, according to people familiar with the selection process.

            Woodcock is expected to serve as acting head of the drug regulator after Biden’s inauguration next week, while being vetted by the Biden team for the permanent job along with former FDA principal deputy commissioner Joshua Sharfstein, according to the people."

            Read the full news article:  FDA Veteran Woodcock Being Considered to Lead Agency Under Biden - Bloomberg News

            Return to SkillsPlus International Info Blog - Home

            Thursday, January 7, 2021

            6 Things We Need From FDA Before Full 2023 DSCSA Enforcement - BioProcess Online

            According to the article:

            "The journey to industry compliance with the U.S. Drug Supply Chain Security Act (DSCSA) continues to twist and turn with recent requirements going into effect for distributors and dispenser and subsequent delays on enforcement of some of those requirements until Nov. 27, 2023."

            "The discussions and perspectives in the meeting were often conflicting and sometimes seemed to ignore insights developed over the past years by several industry workgroups. We would like to suggest some concrete actions the FDA can take now to help bring together a complex and diverse number of sectors in advance of 2023 enforcement:"

            Read the full source article:  6 Things We Need From FDA Before Full 2023 DSCSA Enforcement - BioProcess Online

            Return to SkillsPlus International Info Blog - Home

            ------

            SkillsPlus Intl Inc. - The Best GMP Training & cGMP Training Around
            Free GMP Training Tips
            Root Cause Analysis - GMP Training
            Deviation Investigation Report Writing - GMP Training
            Qualstar Simulation - Advanced GMP Training That's Fun!

             

            Saturday, December 26, 2020

            The 10 Best – And 10 Worst – Things You Can Do When FDA Inspects Your Firm - Medtech Insight

            According to the article:

            "Executive Summary

            From our archives: Despite the COVID-19 pandemic severely curtailing the US FDA’s ability to conduct on-site facility inspections, it’s still vitally important for manufacturers to remain audit-ready. In this collection of a 10-part Compliance Corner series, four longtime industry experts share evergreen advice on the best and worst things firms could do during an inspection."

            Read the full source article:  The 10 Best – And 10 Worst – Things You Can Do When FDA Inspects Your Firm - Medtech Insight

            Return to SkillsPlus International Info Blog - Home

            ---------

            SkillsPlus Intl Inc. - The Best GMP Training & cGMP Training Around
            Free GMP Training Tips
            Root Cause Analysis - GMP Training
            Deviation Investigation Report Writing - GMP Training
            Qualstar Simulation - Advanced GMP Training That's Fun!